Skip to main content

News of Note—Pfizer, Sanofi Pasteur and more

In this week's News of Note, GeoVax teamed with Emory University on a therapeutic HPV vaccine. (Pixabay)

> Pfizer's vaccine sales grew 10% in the second quarter to $1.4 billion. Release

> Sanofi's vaccines sales slipped during the second quarter due to a supply issue in China; timing of government orders for its polio, pertussis and Hib franchise; and a tough year-over-year comparison for Menactra. Release

> GeoVax teamed with Emory University to develop a therapeutic HPV vaccine. Release


Veeva 2020 Unified Clinical Operations Survey

We believe you have the knowledge and expertise to make this year's Veeva 2020 Clinical Operations Report even more robust and insightful than the last. Please take a moment to share your opinion in this 10-minute survey. All qualified respondents will be entered to win a $500 Amazon gift card.

> Sanofi cut a phase 2 tuberculosis vaccine from its pipeline. Endpoints News story

Suggested Articles

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.

Univercells's new CDMO, Exothera, is hoping to play a role in helping drugmakers scale up manufacturing for a possible COVID-19 vaccine.

CanSino and its partners won a go-ahead to move a recombinant coronavirus vaccine into phase 1 testing in Wuhan, China, once the outbreak's center.